{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:30:56Z","timestamp":1767652256837},"reference-count":12,"publisher":"Korean College of Neuropsychopharmacology","issue":"2","license":[{"start":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T00:00:00Z","timestamp":1440979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0"}],"content-domain":{"domain":["www.cpn.or.kr"],"crossmark-restriction":true},"short-container-title":["Clin Psychopharmacol Neurosci"],"published-print":{"date-parts":[[2015,8,31]]},"DOI":"10.9758\/cpn.2015.13.2.209","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T01:13:13Z","timestamp":1438737193000},"page":"209-211","update-policy":"http:\/\/dx.doi.org\/10.9758\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report"],"prefix":"10.9758","volume":"13","author":[{"given":"Sang Won","family":"Jeon","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4713","reference":[{"key":"ref1","unstructured":", (2010). Guidance on the use of zanamivir, olsetamivir and amantadine for the treatment of influenza: Technology appraisal guidance: Array."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3310\/hta7350"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/0002018-200831120-00006"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39240.497025.80"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/446358a"},{"key":"ref6","unstructured":", (2011). Safety alerts for drugs, biologist, medical devices, and dietary supplements. The FDA safety information and adverse event reporting program. New York: US Food and Drug Administration."},{"key":"ref7","unstructured":", (2007). Working group for clinical investigation for oseltamivir phosphate. Boston: US Ministry of Health."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Matheson, NJ, Harnden, AR, Perera, R, Sheikh, A, and Symmonds-Abrahams, M (2007). Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev. <em><\/em>, CD002744.","DOI":"10.1002\/14651858.CD002744.pub2"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.08.054"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.30.1816"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.018556"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Hama, R (2008). Fatal neuropsychiatric adverse reactions to oseltamivir: Case series and overview of casual relationships. Int J Risk Saf Med. <em>20<\/em>, 5-36.","DOI":"10.3233\/JRS-2008-0431"}],"container-title":["Clinical Psychopharmacology and Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2015\/013\/cpn-13-209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T06:08:03Z","timestamp":1723010883000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2015.13.2.209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,31]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8,31]]}},"alternative-id":["10.9758\/cpn.2015.13.2.209"],"URL":"https:\/\/doi.org\/10.9758\/cpn.2015.13.2.209","relation":{},"ISSN":["1738-1088","2093-4327"],"issn-type":[{"type":"print","value":"1738-1088"},{"type":"electronic","value":"2093-4327"}],"subject":[],"published":{"date-parts":[[2015,8,31]]},"assertion":[{"value":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2015.13.2.209","URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2015.13.2.209","name":"the_journal","label":"Clinical Psychopharmacology and Neuroscience","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2014-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2015 The Korean College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}